[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].
Van de Werf
Frans
F
Bax
Jeroen
J
Betriu
Amadeo
A
Blomstrom-Lundqvist
Carina
C
Crea
Filippo
F
Falk
Volkmar
V
Filippatos
Gerasimos
G
Fox
Keith
K
Huber
Kurt
K
Kastrati
Adnan
A
Rosengren
Annika
A
Steg
P Gabriel
PG
Tubaro
Marco
M
Verheugt
Freek
F
Weidinger
Franz
F
Weis
Michael
M
Vahanian
Alec
A
Camm
John
J
De Caterina
Raffaele
R
Dean
Veronica
V
Dickstein
Kenneth
K
Filippatos
Gerasimos
G
Funck-Brentano
Christian
C
Hellemans
Irene
I
Kristensen
Steen Dalby
SD
McGregor
Keith
K
Sechtem
Udo
U
Silber
Sigmund
S
Tendera
Michal
M
Widimsky
Petr
P
Zamorano
José Luis
JL
Silber
Sigmund
S
Aguirre
Frank V
FV
Al-Attar
Nawwar
N
Alegria
Eduardo
E
Andreotti
Felicita
F
Benzer
Werner
W
Breithardt
Ole
O
Danchin
Nicholas
N
Di Mario
Carlo
C
Dudek
Dariusz
D
Gulba
Dietrich
D
Halvorsen
Sigrun
S
Kaufmann
Philipp
P
Kornowski
Ran
R
Lip
Gregory Y H
GY
Rutten
Frans
F
Societá Europea di Cardiologia
D000465:Algorithms; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D042241:Early Diagnosis; D004562:Electrocardiography; D004638:Emergency Treatment / Q000379:methods; D005062:European Union; D019317:Evidence-Based Medicine; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology / Q000534:rehabilitation / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D016019:Survival Analysis; D015912:Thrombolytic Therapy / Q000379:methods*
D000933:Antifibrinolytic Agents